LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $21,659,702

Key CONT_AWD_75N91021F00017_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 15 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91021F00017_7529_75N91019D00024_7529

At the source https://www.usaspending.gov/award/CONT_AWD_75N91021F00017_7529_75N91019D00024_7529

Observed 2026-09-05, version 1, retrieved 2026-09-05T00:54:46Z

Content hash 6aae6d8b0b3af3593cb4be5df1b84fece72c69493af6fabfec40cb41ec84459d

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

Version	Amount	Change	Occurred	Published	Retrieved	How it arrived	Content hash
1 current	$21,659,702	first version	September 16, 2021	August 21, 2026	2026-09-05T00:54:46Z	historical sweep	`6aae6d8b0b3a`

Archived copy

https://web.archive.org/web/20261011162552/https://www.usaspending.gov/award/CONT_AWD_75N91021F00017_7529_75N91019D00024_7529 found, made by someone else, October 11, 2026

What the amount is made of

6 recorded actions, so the amount is the award's current total across all of them. 3 of them obligated money. Measured 2026-10-12, when USAspending reported a total obligation of $21,659,702.

Action date	Modification	Type	Obligated	Description as recorded
August 21, 2026	P00005	EXERCISE AN OPTION	+$11,687,558	ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENT
August 18, 2025	P00004	TERMINATE FOR CONVENIENCE (COMPLETE OR PARTIAL)	−$2,177,307	EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI
April 29, 2025	P00003	TERMINATE FOR CONVENIENCE (COMPLETE OR PARTIAL)	no money	EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI
December 18, 2024	P00002	OTHER ADMINISTRATIVE ACTION	no money	ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENT
February 23, 2024	P00001	SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE	no money	ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENT
September 16, 2021	base	not on file	+$12,149,451	ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENT

Last refreshed November 4, 2026 at 2:31 PM UTC.